HEADER HYDROLASE 08-SEP-15 5ANV TITLE MTH1 IN COMPLEX WITH COMPOUND 15 COMPND MOL_ID: 1; COMPND 2 MOLECULE: 7,8-DIHYDRO-8-OXOGUANINE TRIPHOSPHATASE; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: MTH1,2-HYDROXY-DATP DIPHOSPHATASE, 8-OXO-DGTPASE, NUCLEOSIDE COMPND 5 DIPHOSPHATE-LINKED MOIETY X MOTIF 1, NUDIX MOTIF 1; COMPND 6 EC: 3.6.1.55, 3.6.1.56; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VARIANT: GOLD KEYWDS HYDROLASE, NUDT1, NUDIX HYDROLASE, INHIBITOR EXPDTA X-RAY DIFFRACTION AUTHOR J.A.READ,J.BREED REVDAT 3 08-MAY-24 5ANV 1 REMARK REVDAT 2 06-APR-16 5ANV 1 JRNL REVDAT 1 02-MAR-16 5ANV 0 JRNL AUTH J.G.KETTLE,H.ALWAN,M.BISTA,J.BREED,N.L.DAVIES,K.ECKERSLEY, JRNL AUTH 2 S.FILLERY,K.M.FOOTE,L.GOODWIN,D.R.JONES,H.KACK,A.LAU, JRNL AUTH 3 J.W.NISSINK,J.READ,J.S.SCOTT,B.TAYLOR,G.WALKER,L.WISSLER, JRNL AUTH 4 M.WYLOT JRNL TITL POTENT AND SELECTIVE INHIBITORS OF MTH1 PROBE ITS ROLE IN JRNL TITL 2 CANCER CELL SURVIVAL. JRNL REF J.MED.CHEM. V. 59 2346 2016 JRNL REFN ISSN 0022-2623 JRNL PMID 26878898 JRNL DOI 10.1021/ACS.JMEDCHEM.5B01760 REMARK 2 REMARK 2 RESOLUTION. 1.16 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.6 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.16 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 44.58 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 50830 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.204 REMARK 3 R VALUE (WORKING SET) : 0.204 REMARK 3 FREE R VALUE : 0.211 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.950 REMARK 3 FREE R VALUE TEST SET COUNT : 2516 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.16 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.19 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.90 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 3682 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2144 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 3516 REMARK 3 BIN R VALUE (WORKING SET) : 0.2131 REMARK 3 BIN FREE R VALUE : 0.2431 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.51 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 166 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1221 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 27 REMARK 3 SOLVENT ATOMS : 140 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 14.46 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 21.34 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.79870 REMARK 3 B22 (A**2) : 0.11210 REMARK 3 B33 (A**2) : -0.91080 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.166 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.044 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.043 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.042 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.041 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.956 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.958 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 1369 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 1873 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 473 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 33 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 204 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 1369 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 164 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 1713 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.04 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 4.83 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 14.53 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): 14.3581 19.6787 9.2382 REMARK 3 T TENSOR REMARK 3 T11: -0.0152 T22: 0.0029 REMARK 3 T33: -0.0197 T12: 0.0014 REMARK 3 T13: -0.0083 T23: 0.0037 REMARK 3 L TENSOR REMARK 3 L11: 1.1634 L22: 1.2379 REMARK 3 L33: 0.7871 L12: 0.4252 REMARK 3 L13: -0.0716 L23: -0.1413 REMARK 3 S TENSOR REMARK 3 S11: 0.0245 S12: -0.0009 S13: -0.0627 REMARK 3 S21: 0.0167 S22: 0.0308 S23: -0.0114 REMARK 3 S31: -0.0085 S32: -0.0690 S33: -0.0553 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5ANV COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 08-SEP-15. REMARK 100 THE DEPOSITION ID IS D_1290064962. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 06-AUG-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I03 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97625 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 50884 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.160 REMARK 200 RESOLUTION RANGE LOW (A) : 44.600 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 6.200 REMARK 200 R MERGE (I) : 0.04000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 19.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.16 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.19 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 5.00 REMARK 200 R MERGE FOR SHELL (I) : 0.58000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 38.30 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.99 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 4.5 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 30.19500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 33.04500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 30.19500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 33.04500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -1 REMARK 465 ALA A 0 REMARK 465 MET A 1 REMARK 465 GLY A 2 REMARK 465 ASP A 89 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN A 16 CG CD OE1 NE2 REMARK 470 ARG A 25 CG CD NE CZ NH1 NH2 REMARK 470 ASP A 62 CG OD1 OD2 REMARK 470 GLU A 77 CG CD OE1 OE2 REMARK 470 SER A 90 OG REMARK 470 GLU A 100 CD OE1 OE2 REMARK 470 LYS A 114 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 62 -84.69 -92.55 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE RGJ A 1157 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5ANU RELATED DB: PDB REMARK 900 MTH1 IN COMPLEX WITH COMPOUND 15 REMARK 900 RELATED ID: 5ANW RELATED DB: PDB REMARK 900 MTH1 IN COMPLEX WITH COMPOUND 24 DBREF 5ANV A 1 156 UNP P36639 8ODP_HUMAN 42 197 SEQADV 5ANV GLY A -1 UNP P36639 EXPRESSION TAG SEQADV 5ANV ALA A 0 UNP P36639 EXPRESSION TAG SEQRES 1 A 158 GLY ALA MET GLY ALA SER ARG LEU TYR THR LEU VAL LEU SEQRES 2 A 158 VAL LEU GLN PRO GLN ARG VAL LEU LEU GLY MET LYS LYS SEQRES 3 A 158 ARG GLY PHE GLY ALA GLY ARG TRP ASN GLY PHE GLY GLY SEQRES 4 A 158 LYS VAL GLN GLU GLY GLU THR ILE GLU ASP GLY ALA ARG SEQRES 5 A 158 ARG GLU LEU GLN GLU GLU SER GLY LEU THR VAL ASP ALA SEQRES 6 A 158 LEU HIS LYS VAL GLY GLN ILE VAL PHE GLU PHE VAL GLY SEQRES 7 A 158 GLU PRO GLU LEU MET ASP VAL HIS VAL PHE CYS THR ASP SEQRES 8 A 158 SER ILE GLN GLY THR PRO VAL GLU SER ASP GLU MET ARG SEQRES 9 A 158 PRO CYS TRP PHE GLN LEU ASP GLN ILE PRO PHE LYS ASP SEQRES 10 A 158 MET TRP PRO ASP ASP SER TYR TRP PHE PRO LEU LEU LEU SEQRES 11 A 158 GLN LYS LYS LYS PHE HIS GLY TYR PHE LYS PHE GLN GLY SEQRES 12 A 158 GLN ASP THR ILE LEU ASP TYR THR LEU ARG GLU VAL ASP SEQRES 13 A 158 THR VAL HET RGJ A1157 32 HETNAM RGJ 4-(4-CHLORO-2-FLUORO-ANILINO)-6,7-DIMETHOXY-N-METHYL- HETNAM 2 RGJ QUINOLINE-3-CARBOXAMIDE FORMUL 2 RGJ C19 H17 CL F N3 O3 FORMUL 3 HOH *140(H2 O) HELIX 1 1 THR A 44 GLY A 58 1 15 HELIX 2 2 PRO A 112 ASP A 115 5 4 HELIX 3 3 ASP A 119 GLN A 129 1 11 SHEET 1 AA 2 TRP A 32 ASN A 33 0 SHEET 2 AA 2 ARG A 17 LYS A 23 1 O GLY A 21 N ASN A 33 SHEET 1 AB 2 PHE A 35 LYS A 38 0 SHEET 2 AB 2 SER A 4 LEU A 13 -1 O THR A 8 N GLY A 37 SHEET 1 AC 2 MET A 101 GLN A 107 0 SHEET 2 AC 2 ARG A 17 LYS A 23 -1 O VAL A 18 N PHE A 106 SHEET 1 AD 7 THR A 144 VAL A 153 0 SHEET 2 AD 7 LYS A 132 GLN A 140 -1 O LYS A 132 N VAL A 153 SHEET 3 AD 7 HIS A 65 PHE A 74 1 O VAL A 67 N PHE A 133 SHEET 4 AD 7 LEU A 80 THR A 88 -1 O MET A 81 N PHE A 72 SHEET 5 AD 7 SER A 4 LEU A 13 1 O ARG A 5 N ASP A 82 SHEET 6 AD 7 ARG A 17 LYS A 23 -1 O LEU A 19 N VAL A 12 SHEET 7 AD 7 TRP A 32 ASN A 33 1 O ASN A 33 N GLY A 21 SHEET 1 AE 6 THR A 144 VAL A 153 0 SHEET 2 AE 6 LYS A 132 GLN A 140 -1 O LYS A 132 N VAL A 153 SHEET 3 AE 6 HIS A 65 PHE A 74 1 O VAL A 67 N PHE A 133 SHEET 4 AE 6 LEU A 80 THR A 88 -1 O MET A 81 N PHE A 72 SHEET 5 AE 6 SER A 4 LEU A 13 1 O ARG A 5 N ASP A 82 SHEET 6 AE 6 PHE A 35 LYS A 38 -1 O PHE A 35 N VAL A 10 SHEET 1 AF 2 THR A 60 VAL A 61 0 SHEET 2 AF 2 ILE A 91 GLN A 92 -1 O GLN A 92 N THR A 60 SITE 1 AC1 14 TYR A 7 LEU A 9 PHE A 27 ASN A 33 SITE 2 AC1 14 GLY A 34 GLY A 37 PHE A 72 PHE A 74 SITE 3 AC1 14 MET A 81 TRP A 117 ASP A 119 ASP A 120 SITE 4 AC1 14 PHE A 124 PHE A 139 CRYST1 60.390 66.090 36.160 90.00 90.00 90.00 P 21 21 2 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016559 0.000000 0.000000 0.00000 SCALE2 0.000000 0.015131 0.000000 0.00000 SCALE3 0.000000 0.000000 0.027655 0.00000